The efficacy and stem cell toxicity of cladribine and rituximab in the treatment of patients with chronic lymphocytic leukemia: Are all purine analogs created equal?

Tamar Tadmor; Aaron Polliack; Constantine S. Tam

doi:10.3109/10428190903580444

The efficacy and stem cell toxicity of cladribine and rituximab in the treatment of patients with chronic lymphocytic leukemia: Are all purine analogs created equal?

Tamar Tadmor, Aaron Polliack, Constantine S. Tam

Research output: Contribution to journal › Comment / Debate › Other › peer-review

Original language	English
Pages (from-to)	571-573
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	51
Issue number	4
DOIs	https://doi.org/10.3109/10428190903580444
Publication status	Published - Apr 2010
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3109/10428190903580444

Cite this

@article{8aa7822d865c42a8b718b7cb58507194,

title = "The efficacy and stem cell toxicity of cladribine and rituximab in the treatment of patients with chronic lymphocytic leukemia: Are all purine analogs created equal?",

author = "Tamar Tadmor and Aaron Polliack and Tam, {Constantine S.}",

year = "2010",

month = apr,

doi = "10.3109/10428190903580444",

language = "English",

volume = "51",

pages = "571--573",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor & Francis",

number = "4",

}

The efficacy and stem cell toxicity of cladribine and rituximab in the treatment of patients with chronic lymphocytic leukemia: Are all purine analogs created equal? / Tadmor, Tamar; Polliack, Aaron; Tam, Constantine S.
In: Leukemia and Lymphoma, Vol. 51, No. 4, 04.2010, p. 571-573.

Research output: Contribution to journal › Comment / Debate › Other › peer-review

TY - JOUR

T1 - The efficacy and stem cell toxicity of cladribine and rituximab in the treatment of patients with chronic lymphocytic leukemia

T2 - Are all purine analogs created equal?

AU - Tadmor, Tamar

AU - Polliack, Aaron

AU - Tam, Constantine S.

PY - 2010/4

Y1 - 2010/4

UR - http://www.scopus.com/inward/record.url?scp=77953198375&partnerID=8YFLogxK

U2 - 10.3109/10428190903580444

DO - 10.3109/10428190903580444

M3 - Comment / Debate

C2 - 20141447

AN - SCOPUS:77953198375

SN - 1042-8194

VL - 51

SP - 571

EP - 573

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 4

ER -

The efficacy and stem cell toxicity of cladribine and rituximab in the treatment of patients with chronic lymphocytic leukemia: Are all purine analogs created equal?

UN SDGs

Access to Document

Other files and links

Cite this